The real-life variability of CA 125 in ovarian cancer patients.

  title={The real-life variability of CA 125 in ovarian cancer patients.},
  author={Maurie Markman and Elisa Tso and Frederick van Lente and Paul J. Elson and D Odar and Gertrude Peterson and Barbara Kulp and M Sessana},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  volume={22 14_suppl},
5014 Background: CA 125 has proven to be useful in predicting changes that affect prognosis and management of ovarian cancer; however, interpreting variations in the tumor marker is still not well-defined. Our goal was to further understand the analytical variability of CA 125 in a conventional hospital laboratory. METHODS Patients with ovarian or primary peritoneal cancer, who received active therapy at the Cleveland Clinic Foundation from July 2003 to December 2003, were included in this… CONTINUE READING